China Wholesale in Vitro Diagnostic Reagent Filling – COVID-19 Detection reagent equipment – CILIANG
China Wholesale in Vitro Diagnostic Reagent Filling – COVID-19 Detection reagent equipment – CILIANG Detail:
Neutralizing antibody against SARS-CoV-2 can resist human immune SARS-CoV-2 infection.
Therefore, the detection of neutralizing antibodies against SARS-CoV-2 has important clinical significance for patients with convalescent infection or for vaccination of SARS-CoV-2 vaccine.
The SARS-CoV-2 Neutralizing Antibody Test Kit is for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in human serum, plasma or whole blood sample. The test kit is intended for use outside the body only (in vitro diagnostic use) for professional use and should not be used to diagnose acute SARS-CoV-2 infection.
Analyzer
Test Kit
Product
Method
Specimen type
Specimen volume
Test time
Package size
Storage
SARS-CoV-2 Neutralizing Antibody Test Kit
Fluorescence Immunochromatography
Serum, plasma or whole blood sample
25µl
10 minutes
25 pcs/box; 50 pcs/box
4℃~30℃
Product detail pictures:
Related Product Guide:
With our excellent management, strong technical capability and strict quality control system, we continue to provide our clients with reliable quality, reasonable prices and excellent services. We aim at becoming one of your most reliable partners and earning your satisfaction for China Wholesale in Vitro Diagnostic Reagent Filling – COVID-19 Detection reagent equipment – CILIANG, The product will supply to all over the world, such as: Surabaya, UK, Israel, Our market share of our products and solutions has greatly increased yearly. If you are interested in any of our products or would like to discuss a custom order, make sure you feel free to contact us. We've been looking forward to forming successful business relationships with new clients around the world in the near future. We've been looking forward to your inquiry and order.
By Lauren from Lithuania - 2017.07.07 13:00
Managers are visionary, they have the idea of "mutual benefits, continuous improvement and innovation", we have a pleasant conversation and Cooperation.
By Ruth from Lithuania - 2018.11.11 19:52